Підписатись
Alexander Vaiserman
Alexander Vaiserman
Head of the Laboratory of Epigenetics, Institute of Gerontology, Kiev, Ukraine
Підтверджена електронна адреса в geront.kiev.ua
Назва
Посилання
Посилання
Рік
Association between body mass index and Firmicutes/Bacteroidetes ratio in an adult Ukrainian population
A Koliada, G Syzenko, V Moseiko, L Budovska, K Puchkov, V Perederiy, ...
BMC microbiology 17, 1-6, 2017
9162017
Gut microbiota: A player in aging and a target for anti-aging intervention
AM Vaiserman, AK Koliada, F Marotta
Ageing research reviews 35, 36-45, 2017
4122017
Telomere length as a marker of biological age: state-of-the-art, open issues, and future perspectives
A Vaiserman, D Krasnienkov
Frontiers in Genetics 11, 630186, 2021
2392021
Health impacts of low-dose ionizing radiation: current scientific debates and regulatory issues
A Vaiserman, A Koliada, O Zabuga, Y Socol
Dose-Response 16 (3), 1559325818796331, 2018
2162018
Association between type 2 diabetes and prenatal exposure to the Ukraine famine of 1932–33: a retrospective cohort study
LH Lumey, MD Khalangot, AM Vaiserman
The lancet Diabetes & endocrinology 3 (10), 787-794, 2015
1942015
Epigenetic programming by early‐life stress: Evidence from human populations
AM Vaiserman
Developmental Dynamics 244 (3), 254-265, 2015
1712015
Early-life exposure to endocrine disrupting chemicals and later-life health outcomes: an epigenetic bridge?
A Vaiserman
Aging and disease 5 (6), 419, 2014
1552014
Radiation hormesis: historical perspective and implications for low-dose cancer risk assessment
AM Vaiserman
Dose-Response 8 (2), dose-response. 09-037. Vaiserman, 2010
1492010
Nanodelivery of natural antioxidants: An anti-aging perspective
A Vaiserman, A Koliada, A Zayachkivska, O Lushchak
Frontiers in bioengineering and biotechnology 7, 447, 2020
1392020
Anti-aging pharmacology: promises and pitfalls
AM Vaiserman, V Lushchak, AK Koliada
Ageing research reviews 31, 9-35, 2016
1352016
Differences in the gut Firmicutes to Bacteroidetes ratio across age groups in healthy Ukrainian population
A Vaiserman, M Romanenko, L Piven, V Moseiko, O Lushchak, ...
BMC microbiology 20, 1-8, 2020
1232020
Hormesis and epigenetics: is there a link?
AM Vaiserman
Ageing research reviews 10 (4), 413-421, 2011
1122011
Metformin as a geroprotector: experimental and clinical evidence
V Piskovatska, N Stefanyshyn, KB Storey, AM Vaiserman, O Lushchak
Biogerontology 20, 33-48, 2019
1092019
Early-life adversity and long-term neurobehavioral outcomes: epigenome as a bridge?
AM Vaiserman, AK Koliada
Human genomics 11, 1-15, 2017
992017
HDAC inhibitors: A new promising drug class in anti-aging research
EG Pasyukova, AM Vaiserman
Mechanisms of ageing and development 166, 6-15, 2017
992017
Early-life nutritional programming of longevity
AM Vaiserman
Journal of developmental origins of health and disease 5 (5), 325-338, 2014
982014
Epidemiologic evidence for association between adverse environmental exposures in early life and epigenetic variation: a potential link to disease susceptibility?
A Vaiserman
Clinical epigenetics 7, 1-11, 2015
952015
Fucoxanthin and lipid metabolism: A minireview
K Muradian, A Vaiserman, KJ Min, VE Fraifeld
Nutrition, Metabolism and Cardiovascular Diseases 25 (10), 891-897, 2015
942015
Seasonality of birth in children and young adults (0–29 years) with type 1 diabetes in Ukraine
AM Vaiserman, B Carstensen, VP Voitenko, MD Tronko, VI Kravchenko, ...
Diabetologia 50, 32-35, 2007
852007
Hormesis, adaptive epigenetic reorganization, and implications for human health and longevity
AM Vaiserman
Dose-Response 8 (1), dose-response. 09-014. Vaiserman, 2010
802010
У даний момент система не може виконати операцію. Спробуйте пізніше.
Статті 1–20